http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-607390-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60867eeac051ca001adebb32120e016b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-655 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1990-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba3e2f0a66516fd102d97b6713397f31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7f36010b405fc22caee233e744d4cd6 |
| publicationDate | 2000-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-607390-A3 |
| titleOfInvention | Octapeptide analogs of somatostatin having threonine at position six |
| abstract | A compound of formula wherein each of A 1 andnA2 is independently H, C1-6alkyl, C7.nlophenylalkyl, R 1CO, wherein R 1 is C 1-20 alkyl, C 3-20 alkenyl,nC3-20alkynyl, phenyl, naphthyl or C7-phenylalkyl, or R2OCO,nwherein R 2 is C 10-10 alkyl or C 7-10 phenylalkyl with halonprovided that when one of the substituents A! or A2 isnRiCO or R2OCO, the other must be H, eachnX1 and X2 independently of one another are H, F, Cl, Br,nOH, CH 3 or CF 3 with the proviso that at least one ofnX1 and X2 must be H, A3 is Phe or Tyr andnA) is OH, NH 2 or NH-R 3 wherein R 3 is saturatednaliphatic C 14 alkyl, or a pharmaceutically acceptable salt thereofncompounds; a therapeutic composition comprising the samenthe compounds and the method of using the compounds. |
| priorityDate | 1990-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 362.